Prescribe FIT
401 West Town Street Suite 232, Columbus, Ohio, 43215, United States
Overview
Prescribe FIT provides remote patient monitoring (RPM) technology combined with one-on-one virtual lifestyle health coaching specifically for orthopedic practices to optimize patients for surgery and improve musculoskeletal health. The solution pairs technology with personalized coaching and patient outreach to help reduce pain, improve mobility, and decrease weight through nutrition, activity, and lifestyle changes. Led by CEO and Founder Brock Leonti and President and COO Jack Gainer, the company has expanded its footprint in 2023 to practices from Hawaii and Washington to New Jersey and Florida. Prescribe FIT plans several new offerings including remote therapeutic monitoring (RTM) for pain and mobility, a smoking cessation program for surgical optimization, and an AI-driven solution to boost patient engagement. The company says it remains focused on musculoskeletal patients and aims to be an extension of every private orthopedic practice in the country. It raised $4.8M in a Series A to support growth and hiring plans, including adding more health coaches. Prescribe FIT provides a remote monitoring and virtual lifestyle health solution that extends orthopedic care beyond the office to help patients improve musculoskeletal (MSK) health at home through changes to nutrition, physical activity, and lifestyle. The company combines technology with one-on-one coaching and patient outreach to help orthopedic practices stay connected to patients. Its clinical goals include decreasing weight, reducing pain, and improving mobility for patients at home. The startup is led by CEO Brock Leonti and operates from Columbus, Ohio. Prescribe FIT plans to scale its solution in 2023 and beyond using newly raised capital. No operating metrics were disclosed in the article.
- Total raised
- $9M
- Funding rounds
- 2
- Latest round
- Series A
- Latest activity
- Jun 2024
Industries
- Fitness
- Health Care
- mHealth
- SaaS
- Telehealth
Recent funding
Series A
Jun 2024
$5M
Seed
Jan 2023
$4M